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Abstract 
Coxsackie virus infection most commonly manifests itself in the neonatal period as a 
multisystem disease. This life-threatening neonatal infection has been recently treated 
with a new anti-picornaviral drug, pleconaril. In contrast, in adults Coxsackie virus is an 
uncommon source of hepatitis, but Coxsackie virus type B has been described in case 
reports to cause hepatitis. This is the first case report of hepatitis and encephalitis 
secondary to Coxsackie virus type A9 in an adult. This virus was found in a culture of the 
cerebrospinal fluid and was confirmed by PCR. The patient recovered completely without 
specific treatment. 
Introduction 
Viral hepatitis is a well-known cause of acute hepatitis in children and adults. Some 
patients may be asymptomatic while others may have signs and symptoms of acute 
hepatic injury such as abdominal pain, jaundice and malaise. More rarely, viral hepatitis 
may present as fulminant or acute hepatic failure. Among hepatotropic viruses that can 
cause acute hepatitis, the hepatitis A and B viruses are the most common worldwide. 
Others viruses, such as the herpes simplex virus, Epstein-Barr virus and human 
immunodeficiency virus, also result in severe hepatitis. Determining which virus is 
involved can be difficult and, therefore, it is not unusual that the cause of a severe acute 
hepatitis remains unknown. Some viruses, such as adenovirus or enterovirus, may have a 
seasonal presentation. In other cases, the clinical presentation and associated symptoms 
or findings may help narrow the search. Case Rep Gastroenterol 2011;5:617–622 
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The Coxsackie virus belongs to the enterovirus family and is spread by the fecal-oral 
and respiratory routes. 90% of enterovirus infections are asymptomatic or manifest 
simply as an undifferentiated febrile illness [1]. Age, gender and the host’s immune status 
all influence the clinical presentation and infection severity. There are many presentations 
of Coxsackie virus infection. During a typical infection, fever lasts for 24–36 h and then 
declines with simultaneous appearance of nonpruritic, salmon-pink macules and papules 
on the face and upper trunk. The well-known hand, foot, mouth syndrome of Coxsackie 
virus, most commonly group A, affects mainly children. They have fever, oral vesicles and 
peripherally distributed small, tender cutaneous lesions. Petechial and purpuric rashes 
have also been described in Coxsackie virus A9 infections [2]. Meningitis and less 
frequently generalized or focal encephalitis may occur at all ages. Frank encephalitis is a 
very unusual manifestation of Coxsackie virus infection [3]. The enteroviruses account 
for only 11–22% of all cases of encephalitis that are proven to be viral [4]. Numerous 
serotypes have been implicated as causes of encephalitis, but Coxsackie virus types A9, B2 
and B5 are reported most often. Both Coxsackie virus A and B peak during the summer, 
and Coxsackie virus B has a minor peak in the winter. 
23 serotypes from group A and 6 serotypes from group B have been identified. 
Isolation of Coxsackie virus in cell culture is the standard diagnostic method, but many 
group A Coxsackie viruses grow poorly or not at all in vitro [5]. However, PCR is more 
sensitive than cell culture. In liver biopsy tissue, enterovirus RNA has been demonstrated 
by in situ hybridization with a 3H-labeled single-stranded complementary RNA probe 
prepared by in vitro transcription of a Coxsackie virus B3-derived cDNA fragment [6]. 
Most commonly, hepatic involvement with Coxsackie virus is seen in neonates, where 
it is part of a multisystemic illness [7]. The disease is usually severe with a high mortality 
rate. No specific treatment is available, but intravenous immune globulin has been used in 
life-threatening neonatal infections. More recently, 7 neonates were treated with the new 
anti-picornaviral drug, pleconaril [8]. This treatment may decrease viral load and enhance 
patient survival, but it cannot reverse the effects of extensive tissue damage. The rarer 
adult infection typically results in a self-limited febrile illness requiring no treatment. We 
report here a case of adult hepatitis and encephalitis due to Coxsackie virus A9. 
Case Report 
A 65-year-old man was admitted in August 2009 with a 2-week history of fatigue and occasional 
muscular calf pain followed by a new onset of fever, confusion, dizziness and unilateral hearing loss. 
He was known to have hypertension, chronic right leg deep vein thrombosis and atrial fibrillation. 
He was known also for follicular lymphoma and had received his last chemotherapy 5 months prior 
to admission. In the past, he had failed multiple cycles of various regimens of chemotherapy and 
had subsequently failed autologous stem cell transplantation. His medications included furosemide, 
K-Dur, colchicine, delatestryl and coumadin. He had visited the United States 2 weeks prior to 
admission. He had not eaten raw meat or drunk unpasteurised milk and he had not been in contact 
with animals. 
Physical examination revealed a febrile patient (38.6°C) with normal pulse, blood pressure and 
respiratory rate. He was oriented and did not appear to be in distress. He was not jaundiced. The only 
significant findings were a maculopapular rash on the trunk and pronounced hearing loss in the right 
ear. The abdomen was not tender nor was there any hepatosplenomegaly. The liver function studies at 
admission and during hospitalization are listed in table 1. Other abnormal laboratory data on admission 
were: white blood cell count 1.35 × 10
9/l, hemoglobin 101 g/l, platelets 41 × 10
9/l, sodium 134 mEq/l and 
potassium 3.0 mEq/l. A chest radiograph and CT scan of the brain were unremarkable. Abdominal Case Rep Gastroenterol 2011;5:617–622 
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ultrasound showed a normal liver except for focal fatty infiltration; there was no evidence of biliary 
obstruction or visible lymphoma. Further diagnostic tests including hepatitis A IgM, hepatitis C 
antibody, hepatitis B surface antigen and antibody, hepatitis B core antibody and monospot testing were 
all normal. Serum herpes group PCR, EBV IgM, CMV PCR, parvovirus B19 IgM and IgG, HIV and 
varicella zoster IgG were also ordered and were negative. 
Since the patient was felt to be partially immunocompromised, he was started on acyclovir 
empirically to cover for herpes virus before the test results were known. Lumbar puncture was delayed 
because he was anticoagulated with warfarin. He also received ganciclovir, i.v. ceftriaxone, i.v. 
vancomycin and G-CSF as he became febrile and pancytopenic (of note, neutrophils 0.27 × 10
9/l). He 
showed some clinical and biochemical improvement for the first 4 days of admission, but on day 5 he 
presented with a new decline in his cognitive status and a rise in liver enzymes, despite broad-spectrum 
antivirals and antibiotics. CMV PCR came back negative and ganciclovir was stopped. This evolution 
prompted suspicion that another etiology was the cause of the encephalitis and hepatitis. Serology for 
leptospirosis and VDRL were requested. The patient’s anticoagulation was reversed and a lumbar 
puncture was performed. As he was persistently pancytopenic, a bone marrow biopsy was performed 
showing no evidence of hematologic malignancy. At the same time, a percutaneous liver biopsy was 
performed. It showed mild portal, interface and lobular lymphocytic and neutrophilic infiltration, with 
a moderate number of apoptotic bodies and numerous mitoses in hepatocytes, but no viral inclusions 
(fig. 1). There were no PAS-D-positive globules nor stainable iron and immunohistochemistry for 
cytomegalovirus and herpes simplex virus 1 and 2 was negative.  
The patient improved clinically and his liver enzymes started to normalize. Finally, Coxsackie A9 
was found in the cerebrospinal fluid culture and was confirmed by PCR. All empiric treatment was 
stopped and the patient was discharged on day 13 with improving liver function. 
Discussion 
In adults, Coxsackie virus is an uncommon source of hepatitis, but some cases of 
Coxsackie virus type B hepatitis have been reported. In 1962, the first case of Coxsackie 
B5 hepatitis in a pregnant woman was reported [9]. Four years later, a 19-year-old woman 
had acute hepatitis, pleurodynia and myocarditis as manifestations of Coxsackie virus 
type B3 infection [10]. This was the first report of pathological findings in a liver biopsy 
with hepatitis due to Coxsackie virus. In another case report [11], electron microscopy 
examination of liver biopsy demonstrated viral particles in a case of fatal hepatitis 
secondary to Coxsackie virus type B2 and B5. Two others case reports of acute liver 
failure due to Coxsackie virus type B have been published [12, 13]. More recently, a 
Coxsackie virus type B4 anicteric hepatitis was also detected after a rise in antibody titers 
in the serum [14]. 
A generalized Coxsackie A9 infection with pericarditis, meningitis, pneumonitis and 
hepatitis in a neonate was reported in 1984 [15]. Coxsackie A9 virus was isolated from the 
cerebrospinal fluid, urine and feces of the infant. In the adult population, this is the first 
case report of hepatitis and encephalitis secondary to Coxsackie virus type A9 and may 
illustrate the way this particular infection manifests in susceptible adults.  
A review of the epidemiology of Coxsackie virus infection in Taiwan revealed that 
Coxsackie virus A was more prevalent, but that patients with type B were more likely to 
have complications [16]. Of 265 patients with Coxsackie virus A infection, only 5.3% had 
type A9 infection; most presented with fever, skin or ENT manifestations and none of 
these patients had evidence of hepatic necrosis (AST > 3 times normal).  
Our case suggests that the natural history in an immunocompromised host may be 
different and more virulent. A higher index of suspicion for atypical viral infections as a Case Rep Gastroenterol 2011;5:617–622 
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cause of hepatitis may be warranted, and perhaps a more extensive evaluation should be 
carried out. It is also unknown whether, in severe cases without improvement, additional 
therapies such as intravenous immune globulin should be given. 
Disclosure Statement 
The authors have no conflict of interest. 
 
 
 
Table 1. Liver function studies during hospitalization 
Hospitalization days   
  1 3 5 6 7 9 12 
ALT,  IU/l  1,202 719  1,375 1,634 1,105 582  179 
AST,  IU/l  1,418 168    1,530   146  026 
Alk Phos, IU/l  0.120 143  0.154  0.174  0.183 158  138 
Total bilirubin, μmol/l  00.44  025  00.44  00.79  00.71  036  026 
Direct bilirubin, μmol/l  00.13     00.36  00.33  013  008 
INR  02.98   02.97  01.68  01.22    
LDH, IU/l  1,554    2,098    0.344 212  191 
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Fig. 1. a Medium power light photomicrograph showing portal area (top) with mild inflammation, 
disarray and mitoses (arrowheads). Hematoxylin and eosin, ×200. Scale bar = 30 μm. b Higher power of 
small central vein and surrounding hepatocytes with mitoses (arrowhead) and apoptotic body (arrow). 
Hematoxylin and eosin, ×400. Scale bar = 15 μm. 
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